Global Antibiotics Market - Analysis By Drug Class (Beta-Lactams, Cephalosporins, Lipopeptide, Others), Mechanism, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)

According to the research report, the Global Antibiotic Market was valued at USD 46.66 Billion in the year 2020 with North America leading the regional market share. Growth in the Antibiotics Market is mainly driven by growth of ageing population, rising technical advancements and increasing awareness of infectious diseases in the global platform. Growing awareness as well as investments in development of new antibiotics in the market is pushing the research and development as well as clinical trials in the world.

Moreover, the trends towards excessive use of antibiotics by the people is putting a risk of growing antimicrobial resistance amongst the citizens which will make the present antibiotics ineffective against disease causing bacteria. This is forcing the world to focus more on improving the clinical research on new antibiotics in the world. With population growth and rising geriatric population, there will be more demand of antibiotics which will push the global antibiotics market even further.

With the outbreak of the virus, as much as 95% of the people were prescribed antibiotics for their treatment. These included azithromycin, hydroxychloroquine (a chloroquine derivative of antimalarial drug) among others which proved successful for treatment of virus during the uncertain times. Many people avoided staying in the hospitals for a longer duration during the pandemic, thus prescribing antibiotics seemed the only way out. With more patients getting prescribed with antibiotics, there was an increase in the demand for the same and the antibiotics market faced supply chain shortages.

Scope of the Report

• The report presents the analysis of Antibiotics market for the historical period of 2016-2020 and the forecast period of 2021-2026.
• The report analyses the Antibiotics Market by value (USD Billion)
• The report analyses the Antibiotics Market by Drug Class (Beta-Lactams(Penicillin), Cephalosporins, Lipopeptide, Others)
• The report analyses the Antibiotics Market by Mechanism (Cell Wall Synthesis, Protein Synthesis, DNA Synthesis , Others)
• The Global Antibiotics Market has been analysed By Region (North America, Europe, Asia Pacific and LAMEA)
• The Global Antibiotics Market has been analysed By Country (United States, Canada, Germany, France, United Kingdom, Spain, Italy, China, Japan and India)
• The attractiveness of the market has been presented by region, by Drug Class and by Mechanism.
• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include DEINOVE, Bayer Group, Pfizer Inc., GlaxoSmithKline, Novartis AG, Eli Lilly and Company, Roche Holding AG, Amgen Inc., Johnson & Johnson and Merck KGaA.

Key Target Audience:

• Antibiotics Manufacturers
• Healthcare and Pharmaceutical Companies
• Consulting and Advisory Firms
• Government and Policy Makers
• Regulatory Authorities